19-41197865-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_030622.8(CYP2S1):āc.430G>Cā(p.Glu144Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000434 in 1,614,154 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_030622.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CYP2S1 | NM_030622.8 | c.430G>C | p.Glu144Gln | missense_variant | 3/9 | ENST00000310054.9 | |
CYP2S1 | XM_047438711.1 | c.430G>C | p.Glu144Gln | missense_variant | 3/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CYP2S1 | ENST00000310054.9 | c.430G>C | p.Glu144Gln | missense_variant | 3/9 | 1 | NM_030622.8 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000854 AC: 13AN: 152222Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251286Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135804
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461814Hom.: 0 Cov.: 34 AF XY: 0.0000481 AC XY: 35AN XY: 727202
GnomAD4 genome AF: 0.0000853 AC: 13AN: 152340Hom.: 0 Cov.: 31 AF XY: 0.0000806 AC XY: 6AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 10, 2023 | The c.430G>C (p.E144Q) alteration is located in exon 3 (coding exon 3) of the CYP2S1 gene. This alteration results from a G to C substitution at nucleotide position 430, causing the glutamic acid (E) at amino acid position 144 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at